AMAG Pharmaceuticals to Host Conference Call on May 3, 2016 at 8:00 a.m. ET to Discuss Financial Results for the First Quarte...
April 21 2016 - 8:00AM
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it will
report unaudited consolidated financial results for the first
quarter ended March 31, 2016 before the U.S. financial markets open
on Tuesday, May 3, 2016. The announcement will be followed by a
conference call and webcast with slides at 8:00 a.m. ET, during
which management will provide an update on recent developments and
discuss the company’s first quarter 2016 financial and operating
results.
To access the conference call via telephone, please dial (877)
412-6083 from the United States or (702) 495-1202 for international
access. A telephone replay will be available from approximately
11:00 a.m. ET on May 3, 2016 through midnight on May 10, 2016. To
access a replay of the conference call, dial (855) 859-2056 from
the United States or (404) 537-3406 for international access. The
pass code for the live call and the replay is 90192659.
The call will be webcast with slides and accessible through the
Investors section of the company’s website at www.amagpharma.com.
The webcast replay will be available from approximately 11:00 a.m.
ET on May 3, 2016 through midnight on June 3, 2016.
About AMAGAMAG is a biopharmaceutical company
focused on bringing therapeutics to market that provide clear
benefits and help improve people’s lives. Headquartered in Waltham,
MA, AMAG possesses a diverse portfolio of products to support the
health of patients in the areas of maternal health, anemia
management and cancer supportive care. Through CBR®, the company
also helps families to preserve newborn stem cells, which are used
today in transplant medicine for certain cancers and blood, immune
and metabolic disorders, and have the potential to play a valuable
role in the ongoing development of regenerative medicine. For
additional company information, please visit
www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG
Pharmaceuticals, Inc. CBR® is a registered trademark of CBR
Systems, Inc.
AMAG Pharmaceuticals Contact:
Maryann Cimino
Manager, Corporate Communications & External Affairs
617-498-3375
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Mar 2024 to Apr 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Apr 2023 to Apr 2024